Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sanbexin in Acute Ischemic Stroke
NCT02430350Phase 3Completed
- Sponsor
- Simcere Pharmaceutical Group
- Start
- May 2015
- Primary completion
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of edaravone dexborneol in ischemic stroke, sponsored by Simcere Pharmaceutical Group. Started May 2015; status: completed.
02
Drugs
edaravone dexborneol
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT02430350.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02430350.